Edition:
United Kingdom

WAVE Life Sciences Ltd (WVE.OQ)

WVE.OQ on NASDAQ Stock Exchange Global Market

52.30USD
21 Sep 2018
Change (% chg)

$-0.40 (-0.76%)
Prev Close
$52.70
Open
$52.60
Day's High
$53.15
Day's Low
$52.05
Volume
81,480
Avg. Vol
61,877
52-wk High
$55.95
52-wk Low
$21.00

Chart for

About

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects... (more)

Overall

Beta: --
Market Cap(Mil.): $694.01
Shares Outstanding(Mil.): 27.76
Dividend: --
Yield (%): --

Financials

  WVE.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -3.34 -- --
ROI: -41.61 1.79 14.61
ROE: -45.99 3.28 16.33

BRIEF-Wave Life Sciences Reports Qtrly Loss Per Share $1.26

* WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

09 May 2018

BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders

* WAVE LIFE SCIENCES AND DEEP GENOMICS FORM COLLABORATION TO DISCOVER NOVEL THERAPIES FOR GENETIC NEUROMUSCULAR DISORDERS

10 Apr 2018

Earnings vs. Estimates